Paxman AB (PAX)

Currency in SEK
55.00
+8.10(+17.27%)
Closed·

PAX Earnings

Latest Release
Aug 21, 2026
EPS / Forecast
-- / 0.50
Revenue / Forecast
105M / 98.85M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2026--/0.600--/107.30M----Free Sign Up
06/2026--/0.500105.00M/98.85M--+6.22%Free Sign Up
03/20260.000/--89.80M/94.60M---5.07%Free Sign Up
12/2025-0.400/0.20084.20M/91.85M-300%-8.33%Free Sign Up
09/20250.100/0.20086.95M/96.75M-50%-10.13%Free Sign Up
06/2025-0.100/--74.95M/83.60M---10.35%Free Sign Up
03/2025-0.290/--69.62M/------Free Sign Up
12/20240.600/0.70066.20M/72.30M-14.29%-8.44%Free Sign Up
09/20240.200/0.60064.80M/69.20M-66.67%-6.36%Free Sign Up
06/20240.500/0.50063.00M/63.00M0%0%Free Sign Up

All numbers in SEK

Paxman AB Earnings Call Summary for Q2/2026

  • Paxman Q2 sales surged 40% YoY to record 105.1M SEK; EBITDA hit 14M SEK with 13% margin; shares jumped 15.35% to $54.1 in premarket trading.
  • U.S. revenue climbed 77.5% to $7.1M driven by insurance-based billing model, which grew 110% quarter-over-quarter with 1,326 caps sold through the program.
  • Company holds 105M SEK cash and 190-system order book; deployed 56 systems in Q2 with 80 units pending installation in U.S. market alone.
  • Management expects continued insurance billing growth but at slower pace; five OneOncology practices signed with Q4 2026 revenue impact anticipated.
  • FDA De Novo application for neuropathy device submitting this month; clearance expected April-August 2027 with U.S. commercialization targeted for Q2 2027.
Last Updated: 08/21/2026, 03:44 PM
Read Full Transcript

FAQ

When Is The Next Paxman Earnings Date?

Paxman will release its next earnings report on Nov 20, 2026.

What Is Paxman’s Revenue Forecasts For Upcoming Quarters?

Paxman’s revenue forecast is 107.30M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.